Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Funding (4)

Research Investigator Pump-Prime Project

2021-01 to present | Award
ICHT (London, GB)
Source: Self-asserted source
Borja Mora Peris

The Indeterminate Retrovirus Infection Service (IDRIS); Novel testing, counselling and management of people with indeterminate HIV results

2018-10 to present | Award
BHIVA (London, GB)
Source: Self-asserted source
Borja Mora Peris

CSF HIV antibodies as a surrogate of HIV activity in the CNS

2018-04 to present | Award
NIHR Imperial Biomedical Research Centre (London, GB)
Source: Self-asserted source
Borja Mora Peris

ImAGE: Reservoir

2017-10 to present | Grant
Gilead UK and Ireland Corporate Contributions (London, GB)
Source: Self-asserted source
Borja Mora Peris

Works (44)

Parvovirus B19 induced acute severe anaemia in a well-controlled HIV-positive individual

Clinical Infection in Practice
2024-01 | Journal article
DOI: 10.1016/j.clinpr.2023.100334
Contributors: Thomas Swaine; Niall Ahmad; Aula Abbara; Borja Mora-Peris; Melissa Wickremasinghe; Christopher Lambert; Anas Khan; Paul Randell
Source: check_circle
Crossref

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.

The Journal of antimicrobial chemotherapy
2023-08-04 | Journal article
DOI: 10.1093/jac/dkad247
PMID: 37539492
Contributors: González-Cordón A; Assoumou L; Moyle G; Waters L; Johnson M; Pere Domingo; Fox J; Stellbrink HJ; Giovanni Guaraldi; Mar Masiá et al.
Source: Self-asserted source
Borja Mora Peris

Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2023-05-19 | Journal article
DOI: 10.1093/cid/ciad297
PMID: 37207617
Contributors: Sempere A; Assoumou L; González-Cordón A; Waters L; Rusconi S; Domingo P; Gompels M; de Wit S; Raffi F; Stephan C et al.
Source: Self-asserted source
Borja Mora Peris

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV.

Scientific reports
2023-03-23 | Journal article
DOI: 10.1038/s41598-023-29739-x
PMID: 36959289
PMC: PMC10036615
Contributors: David M. MacDonald; Samorodnitsky S; Wendt CH; Baker JV; Collins G; Kruk M; Lock EF; Paredes R; Poongulali S; Weise DO et al.
Source: Self-asserted source
Borja Mora Peris

Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.

Open forum infectious diseases
2023-03-01 | Journal article
DOI: 10.1093/ofid/ofad108
PMID: 37152187
PMC: PMC10155812
Contributors: Khan M; Bradshaw D; Brown CS; Haddow J; Patel P; Tosswill JHC; Katrina Pollock; Elliott T; Wang X; Alagaratnam J et al.
Source: Self-asserted source
Borja Mora Peris

HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England.

The Journal of infection
2023-02 | Journal article
DOI: 10.1016/j.jinf.2023.01.033
PMID: 36773896
Contributors: Bradshaw D; Khawar A; Patel P; Tosswill J; Brown C; Ogaz D; Mason E; Osman R; Mitchell H; Dosekun O et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.

The Lancet. Infectious diseases
2023-02-08 | Journal article | Author
DOI: 10.1016/s1473-3099(23)00044-0
PMID: 36773621
PMC: PMC9908088
Contributors: Stafford A; Rimmer S; Gilchrist M; Sun K; Davies EP; Waddington CS; Chiu C; Armstrong-James D; Swaine T; Davies F et al.
Source: Self-asserted source
Borja Mora Peris
grade
Preferred source (of 2)‎

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

The Lancet. Infectious diseases
2022-12-22 | Journal article
DOI: 10.1016/s1473-3099(22)00806-4
PMID: 36566771
Contributors: Fink DL; Callaby H; Luintel A; Beynon W; Bond H; Lim EY; Gkrania-Klotsas E; Heskin J; Bracchi M; Rathish B et al.
Source: Self-asserted source
Borja Mora Peris
grade
Preferred source (of 2)‎

The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2022-11-19 | Journal article | Author
DOI: 10.1016/j.ijid.2022.11.020
PMID: 36410691
PMC: PMC9674568
Contributors: Rimmer S; Barnacle J; Malick M Gibani; Wu MS; Dissanayake O; Mehta R; Herdman T; Gilchrist M; Muir D; Ebrahimsa U et al.
Source: Self-asserted source
Borja Mora Peris
grade
Preferred source (of 2)‎

Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis.

The Lancet. Infectious diseases
2022-07 | Journal article
DOI: 10.1016/s1473-3099(22)00411-x
PMID: 35785793
PMC: PMC9534773
Contributors: Girometti N; Byrne R; Bracchi M; Heskin J; McOwan A; Tittle V; Gedela K; Scott C; Patel S; Gohil J et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Community transmission of monkeypox in the United Kingdom, April to May 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2022-06 | Journal article
DOI: 10.2807/1560-7917.es.2022.27.22.2200422
PMID: 35656834
PMC: PMC9164677
Contributors: Vivancos R; Anderson C; Blomquist P; Balasegaram S; Bell A; Bishop L; Brown CS; Chow Y; Edeghere O; Florence I et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Transmission of monkeypox virus through sexual contact - A novel route of infection.

The Journal of infection
2022-06 | Journal article
DOI: 10.1016/j.jinf.2022.05.028
PMID: 35659548
PMC: PMC9534114
Contributors: Heskin J; Belfield A; Milne C; Brown N; Walters Y; Scott C; Bracchi M; Moore LS; Mughal N; Rampling T et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial.

HIV research & clinical practice
2021-11 | Journal article
PMID: 34743666
Contributors: Mora-Peris B; Keegan MR; Penchala SD; Vera JH; Underwood J; Khan M; Herrera C; Fuchs D; Boasso A; Khoo S et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.

The Journal of antimicrobial chemotherapy
2021-08 | Journal article
DOI: 10.1093/jac/dkab158
PMID: 34120186
Contributors: González-Cordón A; Assoumou L; Moyle G; Waters L; Johnson M; Domingo P; Fox J; Stellbrink HJ; Guaraldi G; Masiá M et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.

The Journal of antimicrobial chemotherapy
2020-11 | Journal article
DOI: 10.1093/jac/dkaa292
PMID: 32737482
Contributors: Gonzalez-Cordon A; Assoumou L; Camafort M; Domenech M; Guaraldi G; Domingo P; Rusconi S; Raffi F; Katlama C; Masia M et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Changes in functional connectivity in people with HIV switching antiretroviral therapy.

Journal of neurovirology
2020-06 | Journal article
DOI: 10.1007/s13365-020-00853-0
PMID: 32500477
PMC: PMC7532134
Contributors: Toniolo S; Cercignani M; Mora-Peris B; Underwood J; Alagaratnam J; Bozzali M; Boffito M; Nelson M; Winston A; Vera JH
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis.

BMJ case reports
2019-07 | Journal article
DOI: 10.1136/bcr-2018-227916
PMID: 31296498
Contributors: Cockbain BC; Mora Peris B; Abbara A; So CW; Cooke G
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2019-02 | Journal article
DOI: 10.1093/cid/ciy505
PMID: 29912307
Contributors: Gatell JM; Assoumou L; Moyle G; Waters L; Johnson M; Domingo P; Fox J; Martinez E; Stellbrink HJ; Guaraldi G et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study.

AIDS (London, England)
2018-02 | Journal article
DOI: 10.1097/qad.0000000000001786
PMID: 29438199
Contributors: Mora-Peris B; Bouliotis G; Ranjababu K; Clarke A; Post FA; Nelson M; Burgess L; Tiraboschi J; Khoo S; Taylor S et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Cognitive Impairment in a Clinical Setting.

Journal of acquired immune deficiency syndromes (1999)
2018-01 | Journal article
DOI: 10.1097/qai.0000000000001547
PMID: 28902706
Contributors: Ferretti F; Mora-Peris B; Underwood J; Waldman A; Everitt A; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.

The British journal of radiology
2016 | Journal article
DOI: 10.1259/bjr.20150979
PMID: 26954329
PMC: PMC4846219
Contributors: Scott J; Underwood J; Garvey LJ; Mora-Peris B; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Evolution of changes in cognitive function after the initiation of antiretroviral therapy.

AIDS research and therapy
2016 | Journal article
DOI: 10.1186/s12981-016-0104-0
PMID: 27081393
PMC: PMC4831200
Contributors: Mora-Peris B; Stevens E; Ferretti F; Underwood J; Taylor S; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Journal of the International AIDS Society
2016-10 | Journal article
DOI: 10.7448/ias.19.8.21487
PMID: 27780519
PMC: PMC5080528
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

The Journal of antimicrobial chemotherapy
2016-01 | Journal article
DOI: 10.1093/jac/dkv326
PMID: 26472771
Contributors: Mora-Peris B; Winston A; Garvey L; Else LJ; Shattock RJ; Herrera C
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.

The Journal of antimicrobial chemotherapy
2015 | Journal article
DOI: 10.1093/jac/dkv035
PMID: 25693997
Contributors: Mora-Peris B; Else L; Goldmeier D; Mears A; Weston R; Cooke G; Khoo S; Back D; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age.

HIV clinical trials
2015 | Journal article
DOI: 10.1179/1528433614z.0000000006
PMID: 25777188
Contributors: Vera JH; Jackson A; Dickinson L; Else L; Barber T; Mora-Peris B; Back D; Boffito M; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

The New England journal of medicine
2015-08 | Journal article
DOI: 10.1056/nejmoa1506816
PMID: 26192873
PMC: PMC4569751
Contributors: INSIGHT START Study Group; Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report.

AIDS (London, England)
2015-05 | Journal article
DOI: 10.1097/qad.0000000000000621
PMID: 25909831
PMC: PMC4444421
Contributors: Mora-Peris B; Goldin RD; Muir D; Main J; Gellissen R; Brown A; Barnes E; Cooke G
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2015-04 | Journal article
DOI: 10.1093/cid/ciu976
PMID: 25501988
Contributors: Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avihingsanon A; Chetchotisakd P et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.

HIV medicine
2015-04 | Journal article
DOI: 10.1111/hiv.12227
PMID: 25711317
PMC: PMC4347998
Contributors: INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group; Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy.

The Journal of antimicrobial chemotherapy
2014-06 | Journal article
DOI: 10.1093/jac/dku018
PMID: 24521854
Contributors: Mora-Peris B; Watson V; Vera JH; Weston R; Waldman AD; Kaye S; Khoo S; Mackie NE; Back D; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects.

The Journal of antimicrobial chemotherapy
2013-06 | Journal article
DOI: 10.1093/jac/dkt006
PMID: 23364475
Contributors: Mora-Peris B; Croucher A; Else LJ; Vera JH; Khoo S; Scullard G; Back D; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Raltegravir resistance in the cerebrospinal fluid.

Infection
2013-06 | Journal article
DOI: 10.1007/s15010-013-0409-z
PMID: 23378293
Contributors: Mora-Peris B; Mackie NE; Suan D; Cooper DA; Brew BJ; Winston A
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.

HIV medicine
2010-09 | Journal article
DOI: 10.1111/j.1468-1293.2010.00830.x
PMID: 20408890
Contributors: González R; Castro P; García F; Plana M; Bayas JM; Lafuente S; Serrano B; Mora B; Argelich R; Gatell JM et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Medical eponyms: time for a name change.

Archives of internal medicine
2010-09 | Journal article
DOI: 10.1001/archinternmed.2010.281
PMID: 20837838
Contributors: Mora B; Bosch X
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients.

AIDS (London, England)
2010-08 | Journal article
DOI: 10.1097/qad.0b013e32833c3268
PMID: 20588162
Contributors: Diaz A; Alós L; León A; Mozos A; Caballero M; Martinez A; Plana M; Gallart T; Gil C; Leal M et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

[Neurological focus in a female patient with systemic lupus erythematosus]

Revista clinica espanola
2009-06 | Journal article
DOI: 10.1016/s0014-2565(09)71481-x
PMID: 19635257
Contributors: García Melchor E; Mora Peris B; Espinosa Garriga G
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.

The Journal of antimicrobial chemotherapy
2009-01 | Journal article
DOI: 10.1093/jac/dkn461
PMID: 19001447
Contributors: León A; Martinez E; Milinkovic A; Mora B; Mallolas J; Blanco JL; Larrousse M; Laguno M; Gallart T; Plana M et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.

AIDS research and human retroviruses
2008-12 | Journal article
DOI: 10.1089/aid.2008.0135
PMID: 19025397
Contributors: Mestre G; Garcia F; Martinez E; Milinkovic A; Lopez A; León A; Mora B; Argelich R; Lozano JM; Peña J et al.
Source: Self-asserted source
Borja Mora Peris via Europe PubMed Central

HIV Gag x CD3 soluble TCR bispecific: safety and activity in a first in human trial.

Conference on Retroviruses and Opportunistic Infections, 19-22 February 2023, Seattle, USA. Poster 436
Conference poster | Formal analysis
Contributors: Fox J; Navarro J; Allard SD.; Uriel A; Moreno S; Boffito M,; Post F; Estrada V; Mothe Pujades B; Yuan Y et al.
Source: Self-asserted source
Borja Mora Peris

Identification of barriers to recruitment in studies exploring treatments for sexually transmitted infections.

British Association for Sexual Health and HIV. 26-28 June 2023, Llandudno, UK. Poster P142
Conference poster | Conceptualization
Contributors: Borja Mora Peris; Blake C; Tajik R; Janani L
Source: Self-asserted source
Borja Mora Peris

Changes to LTBI screening in new diagnoses of HIV during the COVID-19 pandemic.

Conference poster | Conceptualization
Contributors: Borja Mora Peris
Source: Self-asserted source
Borja Mora Peris

Luciferase immunoprecipitation systems (LIPS) assay profiles of anti-HIV-specific antibodies in cerebrospinal fluid of people with HIV on antiretroviral therapy.

Conference poster
Contributors: Borja Mora Peris
Source: Self-asserted source
Borja Mora Peris

Unscheduled HIV Care Activity in St Mary’s Hospital During the COVID Peak and Lock-down Period

Conference poster
Contributors: Borja Mora Peris
Source: Self-asserted source
Borja Mora Peris

Peer review (4 reviews for 3 publications/grants)

Review activity for Heliyon. (2)
Review activity for Journal of infection and public health. (1)
Review activity for PloS one. (1)
How many people are using ORCID?